1560PDMajor determinants of delayed access to innovative medicines for metastatic melanoma: The results of Melanoma World Society and European Association of Dermato-Oncology survey.
Annals of Oncology.
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries..
Journal of Clinical Oncology.
Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016.
Journal of Translational Medicine.
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors.
Cancer Chemotherapy and Pharmacology.
hide from search
A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With Docetaxel.
Journal of Cardiovascular Pharmacology.